Related Experiment Video
Updated: Oct 14, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
An Overlooked Link between IgA Nephropathy and Lithium Toxicity: A Case Report
Sushil K Mehandru1, Supreet Kaur1, Aisha Ghias1
1Division of Nephrology & Hypertension, Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, New Jersey, USA.
Lithium treatment for bipolar disorder can cause kidney damage, especially in patients with IgA nephropathy. High sodium-lithium transporter activity in IgA nephropathy may increase lithium accumulation and toxicity.
Area of Science:
- Nephrology
- Pharmacology
- Genetics
Background:
- Lithium is a first-line treatment for bipolar disorder but carries a risk of renal toxicity.
- Sodium-lithium counter-transporter (SLC-T) activity influences lithium metabolism and renal clearance.
- Enhanced SLC-T activity is associated with IgA nephropathy (IgA-N) and other renal conditions.
Observation:
- Patients with IgA-N may have reduced lithium clearance due to high SLC-T activity.
- This can lead to lithium accumulation in renal tubular cells, causing nephrotoxicity even at therapeutic serum levels.
- A case report details lithium-induced tubulointerstitial nephritis coexisting with IgA-N in a long-term lithium user.
Findings:
- The coexistence of IgA-N and lithium nephrotoxicity is rarely reported.
- High SLC-T activity in IgA-N likely contributes to reduced urinary lithium clearance and subsequent nephrotoxicity.
- Lithium accumulation in distal renal tubular cells exacerbates kidney damage.
Implications:
- Patients with bipolar disorder and IgA-N require careful lithium monitoring.
- Frequent renal function assessments and potential dose adjustments are crucial.
- Understanding SLC-T's role may help prevent severe lithium-induced nephropathy.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease III: Interprofessional Care
Mania and Antimanic Drugs: Overview
Nephrotic Syndrome I : Introduction

